Tuesday was a relatively uneventful news day for Pfizer, especially following the pharmaceutical giant's disclosure on Monday ...

Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 95% based on the firm’s underlying fundamentals and the stock’s valuation.

Value investors rely on traditional forms of analysis on key ... now is Pfizer (PFE). PFE is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The stock is trading with P/E ratio ...

One analyst tracking the pharmaceutical stock didn't hesitate to ... Bernstein SocGen's Courtney Breen wrote in her analysis, according to reports, that Pfizer will likely turn to its tried ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other cheap NYSE stocks. On March ...

On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market ... If you are looking for an AI stock that is more promising than PFE but that trades at less than 5 times ...

Investors in Pfizer Inc. (NYSE:PFE) need to pay close attention to the stock based on moves in the options market lately. That... One stock that might be an intriguing choice for investors right ...